Beth Overmoyer, MD, FACP
Dr. Overmoyer is director of the breast cancer research program through Case Medical School and director of the inflammatory breast cancer program at the Dana Farber Cancer Institute. She has obtained funding for clinical/translational research from the NIH, AVON and the American Cancer Society. This experience has enabled Dr. Overmoyer to design clinical trials with scientific correlatives resulting in substantial publications.
Dr. Overmoyer has been the principal investigator for many clinical trials in breast cancer and has mentored hematology-oncology fellows affiliated with Case Medical School and Harvard Medical School. She was director of the clinical trials core at Case Medical School and continues to focus her academic endeavors on new therapies for breast cancer.